Sonnet BioTherapeutics

Sonnet BioTherapeutics is a company listed under the stock ticker SONN (US).

View the org chart displaying its 10 main executives

Most searched biographies at Sonnet BioTherapeutics

• Pankaj Mohan, Chief Executive Officer & Chairman
• Albert Dyrness, Director
• Donald Griffith, Director

Create your alert
to follow the executive moves at Sonnet BioTherapeutics.

Sonnet BioTherapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Sonnet BioTherapeutics

Social media about Sonnet BioTherapeutics

• Sonnet BioTherapeutics on Wikipedia, Google News & Yahoo Finance
• Sonnet BioTherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Pankaj Mohan

Call Sonnet BioTherapeutics at +1 609...

View the org chart

Register to receive your alert

Report an error